Introduction
- Like all trade
unions, the FDA is a democratic organisation. Members elect
representatives to sit on the FDA's ruling executive committee as well
as the general secretary and the president. Overall policy is
controlled by the Annual Delegate Conference which meets every year in
May. All FDA branches are entitled to send delegates to the
conference.
- Branches are the
basic unit of FDA organisation. Most departments and public bodies
employing FDA members have their own branch, although some small
workplaces are amalgamated into a single branch. Most members in
executive agencies are in a common branch with colleagues from the
parent department.
- Each branch is run by
a small committee and has an elected convenor (chair) and secretary.
Many routine negotiations and personal cases are handled by branch
officials, but each branch has a designated negotiator at head office
who handles more serious cases and generally advises the branch on
professional and employment issues.
Objectives and
Purposes
-
The US
Food and Drug Administration (FDA) quality system regulation specifies
a minimum set of requirements that device manufacturers must meet from
design and development through installation and servicing.
-
The FDA
holds senior management accountable for the quality system, which
includes allocating sufficient resources to meet the regulatory
obligations. During formal management review the overall health
of the organisation is presented in terms of compliance,
nonconformities, customer complaints, resources, etc. Senior
management must be engaged and receptive to authorising adjustments as
necessary to ensure the continued suitability of the quality
system.
- FDA must maintain the
balance of protecting and promoting public health. US consumers rely
on FDA to protect them from unsafe medical products and contaminated
food. In determining whether a new product can be marketed to
consumers FDA must make a determination of the benefit versus risk
based on the best available science. New information may later become
available that will require revising our earlier assessment of
benefits and risks.
FDA Inspections
- FDA enforces many
regulations that affect clinical trial and laboratory sites, including
good laboratory practices, good clinical practices, human subjects
protection and requirements for institutional review boards and
clinical investigators. FDA also conducts inspections to audit data
used in approval applications.
- FDA investigators
follow the same basic procedures whether they're inspecting a large
manufacturing plant or a small clinical trial facility. Herein lies
the challenge for those smaller facilities. Clinical trial and
laboratory sites are more likely to be inexperienced with FDA
inspections than are manufacturers, and operations of all sizes and
types have learned the hard way that inexperience can result in less
than optimal interactions with an investigator.
Report
-
FDA has
a responsibility to protect the public health but it cannot do this
important mission alone. FDA cannot personally supervise/inspect the
design, testing, production or use of every medical device, drug, food
or cosmetic product. FDA must work effectively with academia, health
care professionals, consumers, manufacturers, professional
organizations and others as partners to achieve the important outcome
of protecting the public health.
Entrepreneur
who want the information on
Introduction,
Objective & Purpose, FDA Inspections, Management Reviews, Quality
Systems & Policies, Reports can email us to
informer@eth.net ,
primaryinfo@gmail.com
|